[Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer]. [electronic resource]
Producer: 20140624Description: 773-7 p. digitalISSN:- 0253-3766
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Apoptosis -- drug effects
- Capecitabine
- Cell Cycle -- drug effects
- Chemotherapy, Adjuvant
- Deoxycytidine -- analogs & derivatives
- Disease-Free Survival
- Female
- Fluorouracil -- analogs & derivatives
- Follow-Up Studies
- Gastrectomy -- methods
- Humans
- Inhibitor of Apoptosis Proteins -- metabolism
- Male
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Staging
- Oxaloacetates
- Proliferating Cell Nuclear Antigen -- metabolism
- Proto-Oncogene Proteins p21(ras) -- metabolism
- Remission Induction
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Survivin
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.